▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Patients and Healthcare professionals are asked to report any suspected adverse reactions.

In the event of a suspected adverse event, please report it to:

The Drug Surveillance Centre

Roche Products (Ireland) Limited

Telephone: (01) 4690700

Fax: (01) 4690793

Email: ireland.drug_surveillance_centre@roche.com

Alternatively, suspected adverse reactions should be reported to:

HPRA Pharmacovigilance

The Health Products Regulatory Authority

Telephone: (01) 6764971

Fax: (01) 6762517

Website: www.hpra.ie

Email: medsafety@hpra.ie